Brief: Koru Medical Systems Announces 510(K) Submission For Clearance Of Freedomedgen System With A Commercialized Oncology Biologic
30/12/2025 22:36
Dec 30 (Reuters) - KORU Medical Systems Inc KRMD.O: KORU MEDICAL SYSTEMS ANNOUNCES 510(K) SUBMISSION FOR CLEARANCE OF THE FREEDOMEDGE® SYSTEM WITH A COMMERCIALIZED ONCOLOGY BIOLOGIC Source text: ID:nBw1d0kgLa Further company coverage: KRMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Koru Medical Systems
See all newsKoru Medical Systems Inc Reports Results For The Quarter Ended June 30: Earnings Summary
KORU Medical Q2 returns to profit on lower manufacturing costs and higher average selling prices
Brief: KORU Medical Systems Q2 Operating Expenses USD 7.2 Million
Koru Medical Systems Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: Koru Medical Systems - Enters Amendment No. 1 To Supply Agreement With Command Medical Products On June 24, 2026 - SEC Filing